Kidney cancer surgery heart risk study pulled before starting
NCT ID NCT06515431
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study was designed to find out how often people develop hidden heart damage after kidney removal for cancer. Researchers planned to measure a blood marker of heart injury in 120 patients. However, the study was withdrawn before enrolling anyone, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOCARDIAL INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sheffield Teaching Hospitals NHS Foundation Trust
Sheffield, S10 2JF, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict who needs extra therapy after kidney cancer surgery?
- Can a Two-Drug combo outsmart advanced cancers?
- Can a rapid drug switch outsmart advanced kidney cancer?
- Can a new anesthetic shield elderly hearts during surgery?
- Can a new nucleotide analogue boost cancer treatment?
- Can a blast of radiation make immunotherapy work better against kidney cancer?